Tuberculosis (TB), despite being a preventable and treatable disease, remains a significant global health concern. The key to controlling and eventually eliminating TB lies in accurate and timely diagnosis. This article aims to provide an in-depth review of the contemporary diagnostic approaches currently in use in the medical field.
The cornerstone of TB diagnosis is microbiological testing, which includes sputum smear microscopy, culture methods, and nucleic acid amplification tests (NAATs). The latter, such as Xpert MTB/RIF, have revolutionized TB diagnosis by providing rapid and accurate results, including drug resistance information.
Serological tests, which detect antibodies or antigens in the patient's blood, have been largely discredited due to their inconsistent and unreliable results. The World Health Organization (WHO) strongly advises against their use in TB diagnosis.
Radiological tests, particularly chest X-rays, are commonly used in TB diagnosis. However, they cannot confirm TB on their own due to the presence of other conditions that can mimic TB radiologically. Therefore, they are typically used in conjunction with microbiological tests.
IGRAs, which measure the immune response to TB antigens, represent a significant advance in latent TB diagnosis. However, they cannot distinguish between latent and active TB, necessitating further tests for confirmation.
WGS is an emerging tool in TB diagnosis and research. It offers the potential for comprehensive genetic profiling of the TB bacterium, aiding in the detection of drug resistance and strain typing. However, its application is currently limited by cost and technical complexity.
In conclusion, the diagnosis of TB has evolved significantly over the years, with a shift towards rapid, accurate, and comprehensive diagnostic tools. While challenges remain, particularly in resource-limited settings, the continued development and implementation of advanced diagnostic methods are crucial in the global fight against TB.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation